195940 — HK inno.N Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual income statement for HK inno.N, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	598,447	769,786	846,522	828,908	897,142
Cost of Revenue
Gross Profit	323,842	317,915	349,424	375,967	435,073
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	520,977	719,463	794,483	768,289	812,679
Operating Profit	77,470	50,323	52,039	60,619	84,463
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	53,093	27,785	37,818	45,166	71,735
Provision for Income Taxes
Net Income After Taxes	27,897	24,736	38,134	47,199	61,580
Net Income Before Extraordinary Items
Net Income	27,897	24,736	38,134	47,199	61,580
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	27,897	24,736	38,134	47,199	61,580
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,150	988	1,363	1,785	2,290
Dividends per Share